This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200707-1021OCv1 177/9/1002    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Dobis, D. R. Articles by Day, B. J. PubMed PubMed Citation Articles by Dobis, D. R. Articles by Day, B. J.

Modulation of Lymphocyte Proliferation by Antioxidants in Chronic Beryllium Disease

¹ Department of Medicine, Robert H. Hollis Laboratory of Environmental and Occupational Health Sciences, National Jewish Medical and Research Center, Denver, Colorado; and ² Department of Medicine, ³ Department of Preventive Medicine and Biometrics, and ⁴ Department of Immunology, University of Colorado Health Sciences Center, Denver, Colorado

Correspondence and requests for reprints should be addressed to B. J. Day, Ph.D., Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206. E-mail: dayb{at}njc.org

Rationale: Occupational exposure to beryllium (Be) can result in chronic granulomatous inflammation characterized by the presence of Be-specific CD4⁺ T cells. Studies show that oxidative stress plays a role in the pathogenesis of chronic inflammatory disorders.

Objectives: We hypothesized that Be-induced oxidative stress modulates the proliferation of Be-specific CD4⁺ T cells.

Methods: Thirty-three subjects with chronic beryllium disease (CBD), 15 subjects with beryllium sensitization, and 28 healthy normal control subjects were consecutively enrolled from the Occupational and Environmental Health Clinic of the National Jewish Medical and Research Center.

Measurements and Main Results: All studies were performed with Ficoll-Hypaque–isolated peripheral blood mononuclear cells from subsets of the study subjects. Decreased intracellular levels of the thiol antioxidants, glutathione and cysteine, were observed in peripheral blood mononuclear cells from subjects with beryllium sensitization and CBD, as compared with healthy control subjects. Beryllium stimulation decreased intracellular thiol antioxidants by more than 40%, accompanied by increased reactive oxygen species levels and the proliferation of Be-specific blood CD4⁺ T cells from subjects with CBD. Be-induced T-cell proliferation was inhibited by treatment with the thiol antioxidant N-acetylcysteine or the catalytic antioxidant manganese(III) 5,10,15,20-tetrakis(4-benzoic acid)porphyrin (MnTBAP). MnTBAP treatment also inhibited T-cell proliferation in response to the unrelated, MHC class II–restricted antigen tetanus toxoid. Treatment of CBD blood lymphocytes, but not antigen-presenting cells, with MnTBAP decreased Be-induced T-cell proliferation by more than 40%.

Conclusions: Beryllium can mediate a thiol imbalance leading to oxidative stress that may modulate the proliferation and clonal expansion of Be-specific blood CD4⁺ T cells. These data suggest that Be-induced oxidative stress plays a role in the pathogenesis of granulomatous inflammation in CBD.

Key Words: T cells • reactive oxygen species • glutathione • N-acetylcysteine • oxidative stress

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject Chronic beryllium disease is a chronic progressive lung disease characterized by the presence of granulomatous inflammation. Several studies suggest that oxidative stress plays a role in chronic inflammatory disorders. What This Study Adds to the Field Antioxidants inhibit beryllium antigen–stimulated CD4+ T-cell proliferation in peripheral blood mononuclear cells from subjects with chronic beryllium disease, suggesting a potential therapeutic utility of antioxidant molecules in this and similar granulomatous lung diseases.